School of Medicine


Showing 1-10 of 18 Results

  • Michael S. Kapiloff, MD, PhD

    Michael S. Kapiloff, MD, PhD

    Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.

    URL to NCBI listing of all published works:
    http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending

    For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html

  • Irmak Karaca

    Irmak Karaca

    Instructor, Ophthalmology

    BioIrmak Karaca joins the Byers Eye Institute as she is the recipient of the International Council of Ophthalmology, Retina Research Foundation Helmerich One-Year Fellowships Award in 2020. She is a visiting ophthalmologist from Turkey, and currently working as a Clinical Research Fellow with Dr. Do and Dr. Nguyen in the fields of Retina and Uveitis at Stanford. Dr. Karaca also becomes a fellow of both International Council of Ophthalmology and European Board of Ophthalmology in 2018. Dr. Karaca completed her residency at Ege University, Department of Ophthalmology in 2018 and graduated from Hacettepe University, School of Medicine in 2013 in Turkey.
    Dr. Karaca also participated in nationally funded research projects during her residency. Thereby, she had significant contributions on serving the latest technology and treatment modalities to her patients in Turkey, as well as carrying out many new research studies for the scientific field. Besides, she loves performing surgeries as she believes that this is an outstanding chance for her patients to restore their vision.

  • Khizer Khaderi MD, MPH

    Khizer Khaderi MD, MPH

    Clinical Associate Professor, Ophthalmology

    BioDr. Khizer Khaderi is Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Director/Founder of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC), and faculty at the Stanford Institute for Human-Centered AI.

    Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. He founded Vizzario Inc, a perceptual AI company, spun out from HPL. Khaderi has extensive domain expertise in artificial intelligence (AI), virtual reality (VR), augmented reality (AR), mixed reality (MxR), wearables, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems for the metaverse based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building collaborative partnerships across academia and industry.

    Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including the Global Esports Federation, Magic Leap, Riot Games, Intel, Activision, Unity, Epic Games, Google, FB, Microsoft, Apple, NBA, Aerie Pharma, the World Health Organization, and the World Bank.